Skip to main content
ZJAMP Group Co., Ltd. logo

ZJAMP Group Co., Ltd. — Investor Relations & Filings

Ticker · 002758 ISIN · CNE100002029 LEI · 3003009OKT32LB5C0T64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,563 across all filing types
Latest filing 2019-10-29 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002758

About ZJAMP Group Co., Ltd.

https://www.znjtgf.com

ZJAMP Group Co., Ltd. specializes in the comprehensive distribution and supply chain management of agricultural production materials. The company’s core operations encompass the procurement, storage, and sale of essential inputs, including chemical fertilizers such as urea, potash, and compound fertilizers, as well as pesticides, seeds, and agricultural machinery. Beyond product distribution, the organization provides integrated technical services, modern logistics solutions, and agricultural consultancy to enhance crop yields and farming efficiency. By leveraging an extensive network of distribution centers and service stations, the group facilitates the stable supply of high-quality agricultural resources. Its business model focuses on bridging the gap between manufacturers and end-users through efficient resource allocation and value-added services.

Recent filings

Filing Released Lang Actions
第四届董事会第二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the fourth board meeting of Zhejiang Huatong Pharmaceutical Co., Ltd. It includes details about the meeting date, attendance, and voting results on specific agenda items such as the approval of the 2019 third quarter report and a change in accounting policy. The document does not contain the full financial report itself but rather announces the board's approval of the report and policy changes. The length is short (1115 characters), and it references where the full report can be found (on cninfo.com.cn and Securities Times). This fits the pattern of a Board/Management Information announcement, specifically about board meeting resolutions and decisions. Therefore, the appropriate classification is MANG (Board/Management Information).
2019-10-29 Chinese
2019年第三季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled "浙江华通医药股份有限公司 2019 年第三季度报告全文" which translates to "Zhejiang Huatong Pharmaceutical Co., Ltd. 2019 Third Quarter Report Full Text." It contains detailed financial data including consolidated balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the third quarter of 2019. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year (quarterly) indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2019
2019-10-29 Chinese
2019年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2019 second extraordinary shareholders meeting of Zhejiang Huatong Pharmaceutical Co., Ltd. It includes extensive voting results on multiple proposals related to issuance of shares for asset purchase and related party transactions, with percentages of votes for, against, and abstentions. The document specifies the meeting date, voting methods (onsite and online), attendance, and legal compliance. It does not contain financial statements or management discussion but focuses on the official voting outcomes of shareholder resolutions. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is substantial and contains detailed voting data, not just a brief announcement or a report publication notice. Therefore, the correct classification is DVA with high confidence.
2019-10-28 Chinese
2019年第二次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, procedures, and voting results of the 2019 second extraordinary general meeting of shareholders of Zhejiang Huatong Pharmaceutical Co., Ltd. It details the legality of the meeting's convening, the qualifications of attendees, the voting procedures, and the approval of various resolutions related to a major asset purchase and related party transactions. The document is not a financial report, earnings release, or management discussion but a formal legal opinion on the shareholder meeting and its resolutions. This type of document corresponds to Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports official voting results and related legal opinions on the shareholder meeting.
2019-10-28 Chinese
关于完成公司法定代表人工商登记变更的公告
Board/Management Information Classification · 100% confidence The document is an official announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. regarding the completion of the change in the company's legal representative registration with the industrial and commercial authorities. It mentions the election of a new chairman of the board and the subsequent legal representative change. The document is short (615 characters) and focuses on management and board changes, specifically the appointment of a new chairman and legal representative. There is no financial data, no report attached or referenced, and no mention of earnings or other financial results. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2019-10-25 Chinese
上海市广发律师事务所关于公司“华通转债”2019年第一次债券持有人会议的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, procedures, and validity of a bondholders' meeting for Zhejiang Huatong Pharmaceutical Co., Ltd. It details the meeting's call, attendance, voting procedures, and results related to convertible bonds. The document does not contain financial statements or performance data but is a legal opinion on the meeting's compliance with laws and regulations. It is not an annual report, audit report, earnings release, or any financial report. It is also not a simple announcement but a legal opinion letter. This type of document fits best under Regulatory Filings (RNS), which covers legal and compliance documents that do not fit other categories.
2019-10-25 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.